This study looked at the effect of aerobic exercise on blood pressure and blood flow in patients with resistant hypertension. The authors concluded that light and moderate intensity aerobic exercise can improve blood pressure in patients with resistant hypertension.

This study looked at the effectiveness and safety of different baroreflex activation therapy (BAT) devices for resistant hypertension. The authors concluded that BAT devices are effective at reducing blood pressure and maintaining this reduction in patients with resistant hypertension.

This study compared the effectiveness of spironolactone (Aldactone) and renal denervation treatment in patients with resistant hypertension. The authors concluded that spironolactone was more effective at reducing blood pressure than renal denervation in patients with resistant hypertension.  

This study looked at the risks and benefits associated with exercise for patients with hypertension. The authors concluded that the benefits of regular physical activity outweigh the risks and should be recommended for most patients with hypertension. 

This study investigated whether high blood pressure (hypertension) causes thickening of the right chamber of the heart, responsible for pumping blood to the lungs - a condition known as right ventricular hypertrophy.  

This study investigated a combination of telmisartan/amlodipine (Twynsta; TA) and rosuvastatin (Crestor; R) in the treatment of hypertension and high cholesterol. They found that triple therapy with TAR was effective in these patients.

This article investigated the safety and effectiveness of a processed rice bran (PRB) supplement in the management of patients with high blood pressure (BP). The authors concluded that daily consumption of a rice bran supplement with PRB can improve mildly high BP.  

This study examined the effect of beta-blockers on arterial stiffness, blood pressure, and heart rate in patients with hypertension. The authors concluded that beta blockers are more effective than a placebo (control substance with no active effect) at reducing these risk factors. However, beta blockers were overall less effective than current first-line treatments.

This study examined the safety of increasing potassium in the diets of patients with hypertension receiving treatment with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). The authors concluded that increasing dietary potassium in these patients had no negative effect on the level of potassium in their blood.

This study investigated if there is an increased risk of cardiovascular (heart and circulatory system) disease in patients with prehypertension (mild blood pressure elevation).

They found that prehypertension was associated with an increased risk of cardiovascular disease and stroke.